Market Overview

COVID-19 Testing Stocks Move Lower After Abbott Receives EUA For 15-Minute Test

Share:
COVID-19 Testing Stocks Move Lower After Abbott Receives EUA For 15-Minute Test

Abbott Laboratories (NYSE: ABT) announced late Wednesday the receipt of emergency use authorization from the FDA for its $5, 15-minute COVID-19 antigen test.

Abbott's BinaxNOW could be transformative, Morgan Stanley analyst David Lewis said in a note.

The test is bigger and better than expected, given the $5 price point; the fact that it's a nasal swab; its better-than-expected performance; and a higher shipment volume, the analyst said. 

The Sympathy Move: The announcement, though catalyzing a strong upward move in the shares of Abbott, is proving negative for the shares of a host of molecular diagnostic companies that have their own coronavirus tests. 

Quidel Corporation (NASDAQ: QDEL) provides Sofia SARS Antigen and Lyra SARS-CoV-2 molecular tests for detecting SARS-CoV-2.

Co-Diagnostics Inc (NASDAQ: CODX) has an in vitro diagnostic test, the Logix Smart COVID-19 test kit, which uses the company's CoPrimer technology.

It uses a real-time reverse transcriptase polymerase chain reaction process in swabs collected from lower respiratory tract fluids and upper respiratory tract fluids. It received emergency use authorization in early April.

GenMark Diagnostics, Inc's (NASDAQ: GNMK) ePlex SARS-CoV-2 Test is an automated qualitative nucleic acid multiplex assay designed to detect SARS-CoV-2 nucleic acid in nasopharyngeal swabs.

The test received EUA in mid-March. 

Chembio Diagnostics Inc's (NASDAQ: CEMI) antibody test DPP COVID-19 IgM/IgG was among the earliest tests to receive EUA.

Yet the authorization was revoked in mid-June due to performance concerns. The company said in its second-quarter earnings release that it it seeks to reapply for EUA in the third quarter.

Hologic, Inc. (NASDAQ: HOLX) received EUA for its Panther Fusion SARS-CoV-2 test in mid-May. This PCR in vitro diagnostic test is intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal and oropharyngeal swab specimens.

Biomerica, Inc. (NASDAQ: BMRA) has the disposable, one-time-use COVID-19 IgG/IgM Rapid Test. The finger prick test takes about 10 minutes. It can be performed by trained professionals at any location.

Fulgent Genetics Inc's (NASDAQ: FLGT) COVID-19 test is a real-time RT-PCR test, and it received EUA for the test in late May.

Fluidigm Corporation (NASDAQ: FLDM) announced earlier this week that it has received EUA for the Advanta Dx SARS-CoV-2 RT-PCR Assay, an extraction-free, saliva-based test to detect nucleic acid from the SARS CoV 2 virus. The announcement sent the stock higher by 30% Wednesday.

Sorrento Therapeutics Inc (NASDAQ: SRNE) said in late July it has entered into an agreement with Columbia University to license a rapid saliva test for SARS-CoV-2.

The Price Action: The diagnostic testing stocks ended Thursday's session as follows:

  • Abbott shares were 7.85% higher at $111.29.
  • Quidel shares were down 21.7% at $174.56.
  • Co-Diagnostics was down 13.19% at $11.42.
  • GenMark shares dropped 12.77% to $13.12. 
  • Chembio shares slid 17.76% to $3.78. 
  • Hologic gave up 6.63% to close at $61.54.
  • Biomerica shares fell by 2.23% to end the session at $7.47.
  • Fulgent Genetics shares were down 28.08% at $32.22.
  • Fluidigm shares plummeted 26.51% to $8.40. 
  • Sorrento fell by 4.13% to close at $8.13. 

Related Links:

The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight

Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates

Latest Ratings for ABT

DateFirmActionFromTo
Oct 2020Credit SuisseMaintainsOutperform
Oct 2020JefferiesMaintainsBuy
Oct 2020Morgan StanleyMaintainsOverweight

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

 

Related Articles (ABT)

View Comments and Join the Discussion!

Posted-In: CoronavirusAnalyst Color News Health Care Analyst Ratings Movers Trading Ideas General Best of Benzinga

Latest Ratings

StockFirmActionPT
ALGNPiper SandlerMaintains500.0
CHMGDA DavidsonDowngrades37.0
GSXNomura InstinetDowngrades
SNVStephens & Co.Upgrades
PCARArgus ResearchUpgrades108.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com